Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1999
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059811A1 Multi-action particle for structuring biological media
11/25/1999WO1999059715A1 Microencapsulation and electrostatic processing device
11/25/1999WO1999059714A1 Microencapsulation and electrostatic processing method
11/25/1999WO1999059710A1 Methods and apparatus for particle formation
11/25/1999WO1999059709A1 Process for preparing a crystal suspension
11/25/1999WO1999059643A2 Liposomal delivery complex
11/25/1999WO1999059639A1 Solid preparations for oral administration of drugs relating to genes
11/25/1999WO1999059638A2 Compositions and methods for the delivery of nucleic acid molecules
11/25/1999WO1999059637A1 Device for the controlled release of active agents in the gastrointestinal tract with a prolonged pylorus passage
11/25/1999WO1999059634A1 Anti-inflammatory eye drops
11/25/1999WO1999059610A2 Use of lipopeptides or lipoproteins for wound treatment
11/25/1999WO1999059602A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
11/25/1999WO1999059598A1 Use of tricyclic antidepressants for local analgesia
11/25/1999WO1999059596A1 Glucocorticoid receptor antagonists for the treatment of dementia
11/25/1999WO1999059580A1 Preventives/remedies for skin diseases
11/25/1999WO1999059575A1 Compositions comprising organic mono- or dinitrate for treating impotence
11/25/1999WO1999059573A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
11/25/1999WO1999059572A1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
11/25/1999WO1999059571A1 Use of amyloid inhibitors for modulating neuronal cell death
11/25/1999WO1999059558A1 Transdermal therapeutic system containing pergolide
11/25/1999WO1999059557A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
11/25/1999WO1999059556A1 Externally triggered microcapsules
11/25/1999WO1999059555A1 Microencapsulated bioactive agents and method of making
11/25/1999WO1999059554A1 In situ activation of microcapsules
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999WO1999059552A1 Regulated release preparations
11/25/1999WO1999059551A1 Pharmaceutical preparation containing levothyroxine sodium
11/25/1999WO1999059550A1 Novel particulate formulations
11/25/1999WO1999059549A1 Biodegradable sustained-release alginate gels
11/25/1999WO1999059548A1 Controlled drug delivery system using the conjugation of drug to biodegradable polyester
11/25/1999WO1999059547A1 Long-circulating liposomal compositions
11/25/1999WO1999059546A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999WO1999059545A1 Targeted liposomal drug delivery system
11/25/1999WO1999059544A2 Orally disintegrable tablets
11/25/1999WO1999059543A1 A pharmaceutical formulation for nasal administration
11/25/1999WO1999059542A1 Pectic preparations used as medicine carrier
11/25/1999WO1999059541A2 Cyclosporin preparations
11/25/1999WO1999059535A1 Oral composition comprising capsules
11/25/1999WO1999059509A1 Hot fomentations
11/25/1999WO1999059426A2 Crystallization of xylitol, crystalline xylitol product and use thereof
11/25/1999WO1999059405A1 Improved film-forming compositions for protecting animal skin
11/25/1999WO1999052506B1 Particulate active agent support for pulmonary application
11/25/1999WO1999049844A3 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
11/25/1999WO1999048480A3 Method for the production of micro capsules
11/25/1999WO1999047127A8 Hydrophilic and hydrophobic polyether polyurethanes and uses therefor
11/25/1999WO1999043269A9 Veterinary delivery device and method
11/25/1999WO1999042087A3 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
11/25/1999WO1999039740A9 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/25/1999WO1998041226A9 Pharmaceutical combined preparations containing erythropoietin and iron preparations
11/25/1999WO1998018500A8 Improvements in or relating to diagnostic/therapeutic agents
11/25/1999DE19844079A1 New four-layer transdermal system
11/25/1999DE19824650A1 Production of redispersed aqueous polymer dispersion especially useful for coating solid pharmaceutical dosage forms
11/25/1999DE19822820A1 Wound healing composition comprising lipopeptide or lipoprotein that stimulates leukocyte infiltration
11/25/1999DE19822549A1 New suppository formulations for acid-labile drugs
11/25/1999DE19820801A1 Oral dosage form for gatifloxacin, providing reproducible decomposition time and drug release
11/25/1999CA2587022A1 Orally disintegrable tablets
11/25/1999CA2333310A1 Use of tricyclic antidepressants for local analgesia
11/25/1999CA2333203A1 Methods for modulating neuronal cell death
11/25/1999CA2333193A1 Pharmaceutical preparation
11/25/1999CA2332803A1 Multi-action particle for structuring biological media
11/25/1999CA2332649A1 Solid preparations for oral administration of drugs relating to genes
11/25/1999CA2332600A1 Crystallization of xylitol, crystalline xylitol product and use thereof
11/25/1999CA2332545A1 Novel particulate formulations
11/25/1999CA2332328A1 Compositions comprising organic mono- or dinitrate for treating impotence
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332270A1 Cyclosporin preparations
11/25/1999CA2329252A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999CA2329147A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999CA2328596A1 Cytosine deaminase gene
11/25/1999CA2328144A1 Multivalent t cell receptor complexes
11/25/1999CA2327314A1 Soluble t cell receptor
11/25/1999CA2272833A1 Novel histidine derivatives, process for its preparation and uses thereof
11/24/1999EP0958831A1 Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
11/24/1999EP0958823A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
11/24/1999EP0958821A1 Fat emulsion containing xanthine derivative
11/24/1999EP0958814A1 Patch having a thermal effect and its use
11/24/1999EP0958813A1 Sustained-release preparation utilizing thermal change and process for the production thereof
11/24/1999EP0958812A1 Spherical particle groups, process for preparing the same and spherical particulate pharmaceuticals using the same
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999EP0958355A1 Transdermal transport of molecules
11/24/1999EP0958201A1 Valve for aerosol container
11/24/1999EP0958043A1 An apparatus and a method for treating particulate materials
11/24/1999EP0957972A1 Device and method for enhancing transdermal agent flux
11/24/1999EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE
11/24/1999EP0957940A1 Pharmaceutical compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids
11/24/1999EP0957939A1 Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
11/24/1999EP0957938A1 Composition with base of coconut oil and its use
11/24/1999EP0957931A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
11/24/1999EP0957927A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0957900A1 Compositions and methods for topical application of therapeutic agents
11/24/1999EP0957899A2 Dosage form for providing ascending dose of drug
11/24/1999EP0957884A1 Moulding strip calender
11/24/1999EP0957817A1 Locking couplings for osmotic delivery devices
11/24/1999EP0957806A1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h?) LEVELS
11/24/1999EP0892632A4 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/24/1999EP0824342B1 Preparation of formulations for electrotransport drug delivery
11/24/1999EP0666901A4 Method and compositions for removing an alginate from a cutaneous substrate.
1 ... 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 ... 2991